Zenas BioPharma, Inc. (ZBIO) Total liabilities 2023–2025
Zenas BioPharma, Inc. (ZBIO) total liabilities at each fiscal year-end, per SEC filings.
$141.5MFY2025 · since FY2023: $43.8M → $141.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $141.5M | +146.0% |
| FY2024 | $57.5M | +31.3% |
| FY2023 | $43.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice